APA (7th ed.) Citation

X, F., C, Y., Y, H., D, S., C, W., LL, W., . . . J, C. (2024). In vivo CRISPR screens identify Mga as an immunotherapy target in triple-negative breast cancer. Proceedings of the National Academy of Sciences of the United States of America, 121(39), e2406325121. https://doi.org/10.1073/pnas.2406325121

Chicago Style (17th ed.) Citation

X, Feng, et al. "In Vivo CRISPR Screens Identify Mga as an Immunotherapy Target in Triple-negative Breast Cancer." Proceedings of the National Academy of Sciences of the United States of America 121, no. 39 (2024): e2406325121. https://doi.org/10.1073/pnas.2406325121.

MLA (9th ed.) Citation

X, Feng, et al. "In Vivo CRISPR Screens Identify Mga as an Immunotherapy Target in Triple-negative Breast Cancer." Proceedings of the National Academy of Sciences of the United States of America, vol. 121, no. 39, 2024, p. e2406325121, https://doi.org/10.1073/pnas.2406325121.